Immunomodulatory approaches in managing lung inflammation in COVID‐19: a double‐edge sword
Introduction The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
G Verma, M Dhawan, A Saied, G Kaur… - Immunity …, 2023 - europepmc.org
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge
sword - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
sword - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Immunomodulatory approaches in managing lung inflammation in COVID-19: A double-edge sword
G Verma, M Dhawan, ARA Saied… - Immunity …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction The novel coronavirus infectious disease 2019 (COVID-19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a gigantic …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a gigantic …
Immunomodulatory approaches in managing lung inflammation in COVID-19: A double-edge sword
G Verma, M Dhawan, ARA Saied… - Immunity …, 2023 - search.proquest.com
Immunomodulatory approaches in managing lung inflammation in COVID-19: A double-edge
sword Immunomodulatory approaches in managing lung inflammation in COVID-19: A …
sword Immunomodulatory approaches in managing lung inflammation in COVID-19: A …
[PDF][PDF] Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
G Verma, M Dhawan, ARA Saied, G Kaur, R Kumar… - 2023 - academia.edu
Introduction: The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
[HTML][HTML] Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
G Verma, M Dhawan, ARA Saied, G Kaur… - Immunity …, 2023 - ncbi.nlm.nih.gov
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge
sword - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
sword - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
[PDF][PDF] Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
G Verma, M Dhawan, ARA Saied, G Kaur, R Kumar… - 2023 - researchgate.net
Introduction: The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
[PDF][PDF] Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
G Verma, M Dhawan, ARA Saied, G Kaur, R Kumar… - 2023 - scienceopen.com
Introduction: The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …
Immunomodulatory approaches in managing lung inflammation in COVID-19: A double-edge sword.
G Verma, M Dhawan, AA Saied, G Kaur… - Immunity …, 2023 - europepmc.org
The novel coronavirus infectious disease 2019 (COVID-19) which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a gigantic problem. The …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a gigantic problem. The …